Status:
UNKNOWN
Splenic Hilar Nodes in Splenic Flexure Cancer
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Colon Cancer
Metastases, Lymphatic
Eligibility:
All Genders
Brief Summary
Report the incidence of metastases to the splenic hilar lymphnodes from splenic flexure primaries. This mode of spread has not been previously characterized for these tumours.
Eligibility Criteria
Inclusion
- All splenic flexure cancer patients
Exclusion
- No consent to data utilization
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04666883
Start Date
January 1 2021
End Date
March 1 2021
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Tor Vergata
Roma, RM, Italy, 00133